Leading pharma lorazepam recall

The leading pharma lorazepam recall was initiated after the discovery of impurities in certain batches of lorazepam tablets. These impurities, known as nitrosamines, are classified as probable human carcinogens, meaning they have the potential to cause cancer.

Lorazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Leading Pharma, Llc. The primary component is Lorazepam.

Leading drug makers Sun Pharmaceutical Industries and Aurobindo Pharma are recalling products from the US market due to manufacturing issues.

Leading Pharma is recalling nearly 3000 bottles of lorazepam tablets, USP CIV, 0.5 mg (NDC ), because they contain 1-mg tablets rather than 0.5

Leading Pharma Inc. Lorazepam Lupin Cefdinir 250mg Retail BRF 5 Teva Pharmaceuticals - Alprostadil Recall Teva Pharmaceuticals

- TIROSINT-SOL (levothyroxine sodium) Oral Solution by IBSA Pharma. About this recall: IBSA Pharma is voluntarily recalling 27 lots of TIROSINT

Order Lorazepam 0.5 mg Tablet 100 Tablets by Leading Pharma LLC .

Aurobindo Pharma USA Inc. has recalled two lots of quinapril and Lorazepam Oral Concentrate, USP 2mg/ml is being recalled for safety reasons. The

The last Recall Enforcement Report for Lorazepam with NDC was Major Pharmaceuticals ; FDA Recall: Lorazepam. FDA Recall Lorazepam.